Hypercalcemia causes
Hypercalcemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypercalcemia On the Web |
American Roentgen Ray Society Images of Hypercalcemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Luke Rusowicz-Orazem, B.S.
Overview
Hypercalcemia is most commonly caused by hyperparathyroisism and malignancy. Other causes of hypercalcemia include hyperthyroidism, vitamin D toxicity, increased calcium intake, granulomatous diseases ( such sarcoidosis), and various renal disorders.
Causes
Life-Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Severity of hypercalcemia is more related to life-threatening situations rather that particular cause.
Common Causes
- Hyperparathyroidism
- Hypercalcemia of malignancy[4][5]
- Hyperthyroidism
- Hypervitaminosis D[6][7]
- Increased calcium intake
- Chronic kidney disease
- Milk-alkali syndrome
- Hypokalaemic distal renal tubular acidosis
- Sarcoidosis[8]
- Post renal transplantation
Less Common Cause
- Immobilization
- Pagets disease of bone
- Hypervitaminosis A
- Lithium[9]
- Pheochromocytoma
- Adrenal insufficiency
- Rhabdomyolysis
- Acute renal failure
- Theophylline toxicity
- Familial hypocalciuric hypercalcemia
- Methphysial chondrodysplasia
- Conenital lactase deficienccy
- Teriparatide
- Thiazide
- Estrogen
- Idiopathic infantile hypercalcemia (Williams syndrome)
- Mutations of the calcium-sensing receptor
- Subcutaneous fat necrosis
- Cidofovir
- Danazol
- Dexlansoprazole
- Blue diaper syndrome
- Fluoxymesterone
- Gestrinone
- Hypophosphataemia
- Hypophosphatasia
- Nandrolone
- Paricalcitol
- Tamoxifen
- Toremifene
- Dietary phosphate deficiency
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Wieneke JA, Smith A (2008). "Parathyroid adenoma". Head Neck Pathol. 2 (4): 305–8. doi:10.1007/s12105-008-0088-8. PMC 2807581. PMID 20614300.
- ↑ Rodriguez M, Nemeth E, Martin D (2005). "The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism". Am J Physiol Renal Physiol. 288 (2): F253–64. doi:10.1152/ajprenal.00302.2004. PMID 15507543.
- ↑ Kilgo MS, Pirsch JD, Warner TF, Starling JR (1998). "Tertiary hyperparathyroidism after renal transplantation: surgical strategy". Surgery. 124 (4): 677–83, discussion 683–4. doi:10.1067/msy.1998.91483. PMID 9780988.
- ↑ Mirrakhimov AE (2015). "Hypercalcemia of Malignancy: An Update on Pathogenesis and Management". N Am J Med Sci. 7 (11): 483–93. doi:10.4103/1947-2714.170600. PMC 4683803. PMID 26713296.
- ↑ Stewart AF (2005). "Clinical practice. Hypercalcemia associated with cancer". N Engl J Med. 352 (4): 373–9. doi:10.1056/NEJMcp042806. PMID 15673803.
- ↑ Hoeck HC, Laurberg G, Laurberg P (1994). "Hypercalcaemic crisis after excessive topical use of a vitamin D derivative". J. Intern. Med. 235 (3): 281–2. PMID 8120527.
- ↑ Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW (1992). "Hypervitaminosis D associated with drinking milk". N. Engl. J. Med. 326 (18): 1173–7. doi:10.1056/NEJM199204303261801. PMID 1313547.
- ↑ Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E (1997). "gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses". J. Clin. Endocrinol. Metab. 82 (7): 2222–32. doi:10.1210/jcem.82.7.4074. PMID 9215298.
- ↑ Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S (1989). "Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume". J. Clin. Endocrinol. Metab. 68 (3): 654–60. doi:10.1210/jcem-68-3-654. PMID 2918061.